These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20644097)

  • 1. Pitfalls of interim positron emission tomography scanning in diffuse large B-cell lymphoma.
    Hüttmann A; Müller S; Jöckel KH; Dührsen U
    J Clin Oncol; 2010 Sep; 28(27):e488-9; author reply e490-1. PubMed ID: 20644097
    [No Abstract]   [Full Text] [Related]  

  • 2. Both Interim and End-of-Treatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Scans Have Low Value in Diffuse Large B-Cell Lymphoma.
    Adams HJ; Kwee TC
    J Clin Oncol; 2016 Mar; 34(7):765-6. PubMed ID: 26755517
    [No Abstract]   [Full Text] [Related]  

  • 3. Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?
    Meignan M; Itti E; Gallamini A; Haioun C
    Leuk Lymphoma; 2009 Nov; 50(11):1753-6. PubMed ID: 19863178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
    Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL
    Cancer; 2008 Nov; 113(9):2496-503. PubMed ID: 18833583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
    Hemmaway CJ; Danga A; Igbokwe U; Radunovic A
    Br J Haematol; 2012 Sep; 158(6):678. PubMed ID: 22823157
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron emission tomography combined with computed tomography as an integral component in evaluation of primary cardiac lymphoma.
    Lee JC; Platts DG; Huang YT; Slaughter RE
    Clin Cardiol; 2010 Jun; 33(6):E106-8. PubMed ID: 20552627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.
    Itti E; Lin C; Dupuis J; Paone G; Capacchione D; Rahmouni A; Haioun C; Meignan M
    J Nucl Med; 2009 Apr; 50(4):527-33. PubMed ID: 19289424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of radiotherapy in chemoradiation treatment for nodal diffuse large B-cell non-Hodgkin lymphoma].
    Vinogradova YN; Iliin NV
    Vopr Onkol; 2015; 61(1):96-101. PubMed ID: 26016153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FDG-PET in the interim evaluation of therapy response in diffuse large B-cell lymphoma.
    Ellmann A
    Transfus Apher Sci; 2013 Aug; 49(1):40-2. PubMed ID: 23769694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
    Odawara J; Asada N; Aoki T; Yamakura M; Takeuchi M; Ohuchi T; Matsue K
    Br J Haematol; 2007 Mar; 136(5):684. PubMed ID: 17129231
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
    Hofman MS; Fields P; Yung L; Mikhaeel NG; Ireland R; Nunan T
    Br J Haematol; 2007 Jun; 137(5):386. PubMed ID: 17355259
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of interim 18F-FDG PET-CT examination in evaluation of chemotherapy response and prognosis in patients with diffuse large B-cell lymphoma].
    Ding C; Li T; Fan L; Xu W; Li J; Sun J; Ding Q
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):342-4. PubMed ID: 24759025
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
    Kostakoglu L; Goldsmith SJ; Leonard JP; Christos P; Furman RR; Atasever T; Chandramouly A; Verma S; Kothari P; Coleman M
    Cancer; 2006 Dec; 107(11):2678-87. PubMed ID: 17063502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC
    Ann Hematol; 2015 Sep; 94(9):1611-3. PubMed ID: 26063192
    [No Abstract]   [Full Text] [Related]  

  • 15. Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?
    Mikhaeel NG
    Leuk Lymphoma; 2009 Dec; 50(12):1931-6. PubMed ID: 20001245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed response in interim positron emission tomography/computed tomography leads to detection of a gastrointestinal stromal tumor in a patient with mediastinal diffuse large B-cell lymphoma.
    Rehmsmeier C; Kessler T; Koschmieder S; Ross M; Weckesser M; Wessling J; Koehler G; Berdel WE
    J Clin Oncol; 2010 May; 28(14):e215-7. PubMed ID: 20194849
    [No Abstract]   [Full Text] [Related]  

  • 17. The prognostic value of interim positron emission tomography scans combined with immunohistochemical data in diffuse large B-cell lymphoma.
    Fields PA; Mikhaeel G; Hutchings M; van der Walt J; Nunan T; Schey SA
    Haematologica; 2005 Dec; 90(12):1711-3. PubMed ID: 16330454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.
    Dickinson M; Hoyt R; Roberts AW; Grigg A; Seymour JF; Prince HM; Szer J; Ritchie D
    Br J Haematol; 2010 Jul; 150(1):39-45. PubMed ID: 20507301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?
    Juweid ME; Smith B; Itti E; Meignan M
    J Clin Oncol; 2010 Dec; 28(34):e719-20; author reply e721-2. PubMed ID: 20733137
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomography/computerized tomography in the evaluation of primary non-Hodgkin's lymphoma of prostate.
    Pan B; Han JK; Wang SC; Xu A
    World J Gastroenterol; 2013 Oct; 19(39):6699-702. PubMed ID: 24151402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.